Minerva Ginecol: Inositol and D-sol inositol treatments can be a potentially effective treatment for PCOS patients.

Polycystic ovary syndrome (PCOS) is the most common endocrine disease in women of childbearing age.
it is an endocrine and metabolic disease characterized by low ovulation, higher levels of hormones and insulin resistance.
for PCOS, people have tried a variety of treatments, including diet and the use of drugs such as oral contraceptives (OCs) or anti-androgens.
recently, the introduction of inositol in treatment options has been shown to be reasonable because it is useful in combating endocrine metabolic disorders of this syndrome.
This study was designed to compare the clinical, endocrine and metabolic responses of 137 PCOS women, characterized by less menstruation and/or acne and/or mild hair and insulin resistance, after 6 months of treatment.
patients receive inositol or D-snastol or placebo treatment.
results showed that inositol (MI-PG) and D-sol inositol (DCI-PG) treatments significantly improved menstrual cycle regularity, acne scores, endocrine and metabolic parameters, and insulin resistance in young, overweight, PCOS patients.
, of course, we believe that inositol and D-sol inositol therapy can be a potentially effective treatment for PCOS patients.
, further tests and longer treatment times are required.
.